Home > Insider Trading > Filing (0001209191-22-002604)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610618	Cidara Therapeutics Inc.	CDTX	Biological Products, (No Disgnostic Substances) (2836)	461537286

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1639144	Paul Daruwala	6310 Nancy Ridge Drive Suite 101 San Diego CA 92121	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-29	9,900	$0.00	192,431	No	4	M	Direct
Common Stock	Disposition	2022-01-05	5,133	$1.25	187,298	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2021-12-29	5,000	$0.00	5,000	$0.00
Common Stock	Restricted Stock Unit	Disposition	2021-12-29	4,900	$0.00	4,900	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,500		2027-09-17	No	4	M	Direct
5,600		2029-01-30	No	4	M	Direct

Footnotes

The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on December 29, 2021 and January 1, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
On September 18, 2017, the Reporting Person was granted restricted stock units totaling 25,000 shares subject to vesting upon the achievement of various milestones.
On January 31, 2019, the Reporting Person was granted restricted stock units totaling 14,000 shares subject to vesting upon the achievement of various milestones.